Pregabalin, a widely prescribed drug for pain, has spurred significant interest in the development of analogs with potentially improved pharmacological properties. One notable strategy involves incorporating a 1-beta-carboxylic acid oxide (1-BCO) moiety into the pregabalin scaffold, aiming to modify its pharmacodynamics. This article delves into in